What is now disclosed
What the disclosed numbers let us calculate
The table supports several active-yield calculations: 25 mg forskolin, 100 mg EGCG, 44 mg caffeine from guarana, 1.12 mg phenylcapsaicin, 6 mg synephrine, 10 mg 6-paradol, and 1.9 mg piperine. Add the 76 mg caffeine anhydrous and the known caffeine minimum becomes 120 mg.
These are mathematical interpretations of label specifications, not laboratory verification. A percentage can describe the intended standardized material while a batch test would assess whether the sold lot meets specification. A calculated dose also does not establish that the exposure matches an effective or safe dose for every user.

The four material gaps
- All-source caffeine. The page does not state one combined value.
- Green-tea caffeine. EGCG is standardized, but caffeine is not quantified.
- Batch verification. A publicly verifiable, lot-linked certificate or independent certification was not identified.
- Finished-product evidence. We did not identify an independent controlled trial of this exact marketed formula.
Why the remaining gaps still matter
Total caffeine affects comparison, timing, stacking, and personal tolerability. The known 120 mg minimum may be enough to matter for a sensitive user, but an unknown cannot be converted into reassurance. Synephrine belongs in a separate combined-stimulant assessment even though it is not caffeine.
Batch evidence addresses identity, potency, contaminants, and other quality questions only within the methods used. Finished-product trials address average outcomes and adverse events for the combination. Neither can be substituted by ingredient trademarks, percentages, or customer testimonials.
Our updated transparency grade
Formula disclosure: good. The expanded table names forms, daily amounts, and many active percentages. Exposure completeness: partial. The all-source caffeine total remains incomplete. Quality verification: not established from the public information reviewed. Product efficacy evidence: not established.
This is a significant improvement over an ingredient-only sales page, and our main review should reflect it. It does not justify a numerical effectiveness score. Transparency is the ability to ask the next evidence question; it is not the answer to that question.
A useful manufacturer response would state total caffeine per two capsules, confirm whether that total includes green tea, identify the current formula revision, and explain how buyers can verify testing for their lot. Those four answers would reduce uncertainty without requiring the company to promise an outcome. Until then, preserve the gaps explicitly in any comparison or personal exposure calculation.
Before you order
No supplement is necessary for losing body fat, and Fat Burn Active cannot replace a sustainable calorie deficit, adequate nutrition, activity, sleep, or appropriate medical care. If the disclosed formula fits your goal and risk profile, you have reviewed medicines and conditions, and you accept the remaining evidence limits, confirm the current price and terms on the official website. We may receive a commission at no additional cost to you. The commercial relationship does not alter the analysis, and results are not guaranteed.
Practical decision checkpoint
Keep a list of disclosed amounts and unknown totals while reading the current label. If an extract contributes caffeine but the amount is not fully specified, do not calculate a false precise total. Ask the seller for an updated label before making a dose comparison.
Frequently asked questions
Are Fat Burn Active doses disclosed?
Yes. The current official table states amounts for the recommended two-capsule day.
What is still unknown?
Total all-source caffeine, green-tea caffeine, public lot verification, and independent finished-product outcomes remain unresolved.
Does dose transparency prove effectiveness?
No. It enables evidence matching but does not guarantee a favorable result.
Sources
- Fat Burn Active official formula, directions, and manufacturer
- FDA Dietary Supplement Labeling Guide
- 21 CFR 101.36: Supplement Facts
- NIH ODS: Weight-Loss Supplements
Sources reviewed September 13, 2026. This article is general educational information, not medical advice, diagnosis, or treatment.
